Dr. Tammy Leopold, M.D

NPI: 1336329630
Total Payments
$263.09
2018 Payments
$138.12
Companies
2
Transactions
2
Medicare Patients
904
Medicare Billing
$63,873

Payment Breakdown by Category

Food & Beverage$263.09 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $263.09 2 100.0%

Top Paying Companies

Company Total Records Latest Year
Allergan Inc. $138.12 1 $0 (2018)
Gilead Sciences Inc $124.97 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2018 $138.12 1 Allergan Inc. ($138.12)
2017 $124.97 1 Gilead Sciences Inc ($124.97)

All Payment Transactions

2 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/09/2018 Allergan Inc. BOTOX - NEUROLOGY (Drug) Food and Beverage In-kind items and services $138.12 General
Category: NEUROSCIENCE
04/17/2017 Gilead Sciences Inc Truvada (Drug) Food and Beverage In-kind items and services $124.97 General
Category: HIV

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 205 221 $34,055 $12,495
2022 9 265 272 $47,207 $19,737
2021 6 212 216 $43,891 $18,815
2020 6 222 253 $68,877 $12,825
Total Patients
904
Total Services
962
Medicare Billing
$63,873
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 66 69 $14,268 $5,236 36.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 20 20 $6,000 $2,324 38.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 21 21 $6,338 $1,914 30.2%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2023 46 47 $4,500 $1,558 34.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 14 14 $1,722 $818.60 47.5%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2023 12 24 $720.00 $389.28 54.1%
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) Office 2023 13 13 $390.00 $210.60 54.0%
81002 Urinalysis, manual test Office 2023 13 13 $117.00 $44.33 37.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 55 56 $11,520 $5,561 48.3%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2022 91 94 $9,400 $3,276 34.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 22 22 $6,800 $2,545 37.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 20 20 $6,000 $2,408 40.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 12 12 $5,496 $2,083 37.9%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 23 26 $3,198 $1,748 54.7%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2022 16 16 $3,360 $1,382 41.1%
90662 Influenza vaccine split virus, preservative free Office 2022 11 11 $1,298 $682.12 52.6%
81002 Urinalysis, manual test Office 2022 15 15 $135.00 $51.38 38.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 49 50 $10,441 $4,986 47.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 32 33 $10,136 $4,777 47.1%
87426 Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2021 81 83 $8,300 $2,932 35.3%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 23 23 $7,160 $2,790 39.0%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 13 13 $6,113 $2,394 39.2%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 14 14 $1,741 $936.18 53.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 32 32 $20,544 $4,346 21.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 53 65 $21,563 $4,019 18.6%

About Dr. Tammy Leopold, M.D

Dr. Tammy Leopold, M.D is a Internal Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1336329630.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tammy Leopold, M.D has received a total of $263.09 in payments from pharmaceutical and medical device companies, with $138.12 received in 2018. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($263.09).

As a Medicare-enrolled provider, Leopold has provided services to 904 Medicare beneficiaries, totaling 962 services with total Medicare billing of $63,873. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location New York, NY
  • Active Since 11/05/2007
  • Last Updated 02/12/2021
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1336329630

Products in Payments

  • BOTOX - NEUROLOGY (Drug) $138.12
  • Truvada (Drug) $124.97

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in New York